Search Results - "Gregornik, David"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Characterization of complex structural variation in the CYP2D6-CYP2D7-CYP2D8 gene loci using single-molecule long-read sequencing by Turner, Amy J, Derezinski, Ashley D, Gaedigk, Andrea, Berres, Mark E, Gregornik, David B, Brown, Keith, Broeckel, Ulrich, Scharer, Gunter

    Published in Frontiers in pharmacology (22-06-2023)
    “…Complex regions in the human genome such as repeat motifs, pseudogenes and structural (SVs) and copy number variations (CNVs) present ongoing challenges to…”
    Get full text
    Journal Article
  2. 2

    Sertraline dosing trends in children and adolescents stratified by CYP2C19 genotype by Brown, Jacob T, Gregornik, David B, Jorgenson, Alissa, Watson, Dave, Roiko, Samuel A, Bishop, Jeffrey R

    Published in Pharmacogenomics (01-03-2022)
    “…Sertraline is a CYP2C19 substrate commonly prescribed to children with anxiety. This medical record review examined dosing trends and treatment discontinuation…”
    Get full text
    Journal Article
  3. 3

    Synthesis of major pharmacogenomics pretest counseling themes: a multisite comparison by Wake, Dyson T, Bell, Gillian C, Gregornik, David B, Ho, Teresa T, Dunnenberger, Henry M

    Published in Pharmacogenomics (01-02-2021)
    “…The accessibility of pharmacogenomic (PGx) testing has grown substantially over the last decade and with it has arisen a demand for patients to be counseled on…”
    Get full text
    Journal Article
  4. 4

    Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota by Zhang, Lusi, Jacobson, Pamala A., Johnson, Alyssa N. K., Gregornik, David B., Johnson, Steven G., McCarty, Catherine A., Bishop, Jeffrey R.

    Published in Journal of personalized medicine (30-09-2022)
    “…The clinical adoption and implementation of pharmacogenomics (PGx) beyond academic medical centers remains slow, restricting the general population from…”
    Get full text
    Journal Article
  5. 5

    Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children’s Genomic Medicine Consortium by Gregornik, David, Salyakina, Daria, Brown, Marilyn, Roiko, Samuel, Ramos, Kenneth

    Published in The pharmacogenomics journal (01-02-2021)
    “…The advent of digital, electronic, and molecular technologies has allowed the study of complete genomes. Integrating this information into drug development has…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Pharmacogenomics insights into precision pediatric oncology by Ramos, Kristie N., Gregornik, David, Ramos, Kenneth S.

    Published in Current opinion in pediatrics (01-12-2021)
    “…Pharmacogenomic insights provide an opportunity to optimize medication dosing regimens and patient outcomes. However, the potential for interindividual genomic…”
    Get full text
    Journal Article
  8. 8

    Implementation of a Clinical Pharmacogenomics Service in a Large Freestanding Pediatric Health System by Paetznick, Courtney, Gregornik, David, Miller, Lane, Olson, Damon, Brown, Jacob

    Published in Advances in Molecular Pathology (01-11-2022)
    “…As a large, freestanding pediatric health system, Children’s Minnesota is faced with unique challenges and opportunities with pharmacogenomics (PGx)…”
    Get full text
    Journal Article
  9. 9

    A clinician’s guide for counseling patients on results of a multigene pharmacogenomic panel by Ho, Teresa T, Bell, Gillian, Gammal, Roseann S, Gregornik, David, Wake, Dyson T, Dunnenberger, Henry M

    Published in American journal of health-system pharmacy (22-09-2022)
    “…Abstract Purpose This article explores approaches to pharmacogenomic counseling for patients who have undergone multigene panel testing by describing the…”
    Get full text
    Journal Article
  10. 10

    Pharmacokinetics of paclitaxel in an anephric patient by WOO, M. H, GREGORNIK, D, SHEARER, P. D, MEYER, W. H, RELLING, M. V

    “…To assess the pharmacokinetics of paclitaxel for recurrent Wilms' tumor in an anephric pediatric patient receiving hemodialysis. Paclitaxel was administered at…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients by Millisor, Vanessa E., Roberts, Jessica K., Sun, Yilun, Tang, Li, Daryani, Vinay M., Gregornik, David, Cross, Shane J., Ward, Deborah, Pauley, Jennifer L., Molinelli, Alejandro, Brennan, Rachel C., Stewart, Clinton F.

    Published in Pediatric nephrology (Berlin, West) (01-09-2017)
    “…Background and objective Monitoring renal function is critical in treating pediatric patients, especially when dosing nephrotoxic agents. We evaluated the…”
    Get full text
    Journal Article
  15. 15

    The Role of the Pediatric Pharmacist in Precision Medicine and Clinical Pharmacogenomics for Children by Brown, Jacob T, Gregornik, David, Kennedy, Mary Jayne

    “…With the initiatives by the National Institutes of Health and the US Food and Drug Administration, pharmacogenomics is transitioning from the laboratory to…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with wilms tumour by Daw, Najat C, Gregornik, David, Rodman, John, Marina, Neyssa, Wu, Jianrong, Kun, Larry E, Jenkins, Jesse J, McPherson, Valerie, Wilimas, Judith, Jones, Deborah P

    Published in European journal of cancer (1990) (01-01-2009)
    “…Abstract We prospectively evaluated tumour response and renal function in 12 newly diagnosed children with high-risk Wilms tumour receiving ifosfamide,…”
    Get full text
    Journal Article
  18. 18